Abstract:BACKGROUND:Recent evidence has proven that long noncoding RNAs (lncRNAs) play important roles in cancer biology, while few lncRNAs have been characterized in NSCLC. Here, we characterized a novel lncRNA, SBF2 antisense RNA 1 (SBF2-AS1), in non-small cell lung cancer (NSCLC).METHODS:Quantitative real-time PCR was used to quantify SBF2-AS1 expression in NSCLC tissues and cell lines. The correlation of SBF2-AS1 expression with clinicopathologic features was analyzed in a cohort NSCLC patient. Loss of function and gain of function studies were performed to determine the effects of SBF2-AS1 on proliferation and metastasis of NSCLC cells. RNA immunoprecipitation and chromosome immunoprecipitation assay was performed to confirm the interaction between SBF2-AS1 with protein and chromosome.RESULTS:We confirmed that SBF2-AS1 was significantly upregulated in NSCLC compared with corresponding non-tumor tissues, and a high expression level of SBF2-AS1 was correlated with lymph node metastasis and advanced TNM stage. Using siRNAs specifically targeting SBF2-AS1 and plasmid vector, we successfully silenced and overexpressed SBF2-AS1 in NSCCLC cell lines and investigated its biological function both in vitro and in vivo. After the silencing of SBF2-AS1, the metastasis of NSCLC cells was significantly inhibited, the silencing of SBF2-AS1 decreased the proliferation of NSCLC cells, and the cell cycle was arrested at the G1 phase; while overexpression promoted proliferation ability. Xenograft tumor models revealed that the silencing of SBF2-AS1 inhibited tumor growth in vivo. We speculated that SBF2-AS1 might negatively regulate P21. RNA immunoprecipitation discovered that SBF2-AS2 could bind with a core component of polycomb repressive complex2, SUZ12. Additionally chromatin immunoprecipitation assay demonstrated that, after silencing SBF2-AS1, the enrichment of SUZ12 and trimethylation of histone 3 lysine 27 decreased at the promoter region of P21.CONCLUSIONS:We demonstrated that SBF2-AS1 is upregulated in NSCLC and promotes proliferation of NSCLC tumor cells. SBF2-AS1 may serve as a novel biomarker and potential therapeutic target for NSCLC patients.

SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1

Sirt1 Expression Is Associated With The Chemotherapy Response And Prognosis Of Patients With Advanced Nsclc

Sirt2 Suppresses Non-Small Cell Lung Cancer Growth by Targeting Jmjd2a

Regulation of SIRT2 Levels for Human Non-Small Cell Lung Cancer Therapy.

Prognostic and Clinicopathological Significance of SIRT1 Expression in NSCLC: a Meta-Analysis

SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production

Sirtuin Expression is Downregulated in Non‐small Cell Lung Cancer

Silence of S1 RNA Binding Domain 1 Represses Cell Growth and Promotes Apoptosis in Human Non-Small Cell Lung Cancer Cells.

Long Noncoding RNA SNHG10 Sponges miR-543 to Upregulate Tumor Suppressive SIRT1 in Nonsmall Cell Lung Cancer.

Critical Role of Mir-155/Foxo1/ros Axis in the Regulation of Non-Small Cell Lung Carcinomas

Silent Information Regulator 1 Suppresses Epithelial-to-mesenchymal Transition in Lung Cancer Cells Via Its Regulation of Mitochondria Status

Supplementary Figures 1 - 3, Table 1 from SIRT1 Inactivation Evokes Antitumor Activities in NSCLC Through the Tumor Suppressor P27

Expression of Long Non-Coding RNA SFTA1P and Its Function in Non-Small Cell Lung Cancer

High Levels of SIRT1 Expression Enhance Tumorigenesis and Associate with a Poor Prognosis of Colorectal Carcinoma Patients

Sirtuin SIRT6 Suppresses Cell Proliferation Through Inhibition of Twist1 Expression in Non-Small Cell Lung Cancer.

Mechanism of miR-138/sirt-1 axis on proliferation and metastasis of non-small cell lung cancer

Silencing SATB1 with Sirna Inhibits the Proliferation and Invasion of Small Cell Lung Cancer Cells

SIRT1 RNAi Knockdown Induces Apoptosis and Senescence, Inhibits Invasion and Enhances Chemosensitivity in Pancreatic Cancer Cells

High Expression of Long Non-Coding RNA SBF2-AS1 Promotes Proliferation in Non-Small Cell Lung Cancer.

PUB120 Research on the Roles and Molecular Mechanisms of Raf1/p70S6K Signaling Pathway in Non-Small Cell Lung Cancer

The Effects and Mechanisms of SLC34A2 in Tumorigenesis and Progression of Human Non-Small Cell Lung Cancer